Cited by 1,132Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchInflammatory mediators and NSAID effects

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Risk of Alzheimer's disease and duration of NSAID use

Open access

Stewart, Walter F., Kawas, Claudia, Corrada, Maria, Metter, E. Jeffrey·1997·Neurology

DOI 10.1212/wnl.48.3.626

Open this paper in CoChat — free account Open PDF

Abstract

In a longitudinal study of 1,686 participants in the Baltimore Longitudinal Study of Aging, we examined whether the risk of Alzheimer's disease (AD) was reduced among reported users of aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs). In addition, we examined use of acetaminophen, a pain-relief medication with little or no anti-inflammatory activity, to assess the specificity of the association between AD risk and self-reported medications. Information on use of medications was collected during each biennial examination between 1980 and 1995. The relative risk (RR) for AD decreased with increasing duration of NSAID use. Among those with 2 or more years of reported NSAID use, the RR was 0.40 (95% confidence interval [CI]: 0.19-0.84) compared with 0.65 (95% CI: 0.33-1.29) for those with less than 2 years of NSAID use. The overall RR for AD among aspirin users was 0.74 (95% CI: 0.46-1.18), and no trend of decreasing risk of AD was observed with increasing duration of aspirin use. No association was found between AD risk and use of acetaminophen (RR = 1.35; 95% CI: 0.79-2.30), and there was no trend of decreasing risk with increasing duration of use. These findings are consistent with evidence from cross-sectional studies indicating protection against AD risk among NSAID users and with evidence suggesting that one stage of the pathophysiology leading to AD is characterized by an inflammatory process.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1212/wnl.48.3.626

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Boston Naming Test
Kaplan, E., Goodglass, H., Weıntraub, S., & Segal, O. (2001) · Medical Entomology and Zoology · Cited by 4,378
Bayes Estimates for the Linear Model
Lindley, D. V., & Smith, A. F. M. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00885.x · Cited by 2,025
Normal Human Aging: The Baltimore Longitudinal Study on Aging
Shock, N. W., Greulich, R. C., Costa, P. T., Andres, R., Lakatta, E. G., Arenberg, D., & Tobin, J. D. (1984) · University Libraries (University of Maryland) · doi:10.13016/sclw-iccq · Cited by 757
Inverse association of anti‐inflammatory treatments and Alzheimer's disease
Breitner, J. C. S., Gau, B. A., Welsh-Bohmer, K. A., Plassman, B. L., McDonald, W. M., Helms, M. J., & Anthony, J. C. (1994) · Neurology · doi:10.1212/wnl.44.2.227 · Cited by 569
Activation of the classical complement pathway in brain tissue of Alzheimer patients
McGeer, P. L., Akiyama, H., Itagaki, S., & McGeer, E. G. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90843-4 · Cited by 383
Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes.
Stremmel, W., Strohmeyer, G. W., Borchard, F., Kochwa, S., & Berk, P. D. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.1.4 · Cited by 350
A Population-Based Study of the Risk of Recurrence of Birth Defects
Lie, R. T., Wilcox, A. J., & Skjærven, R. (1994) · New England Journal of Medicine · doi:10.1056/nejm199407073310101 · Cited by 164
Social adjustment and psychopathology among formerly hospitalized and non-hospitalized mothers—I. Development of the social role adjustment instrument
Cohler, B. J., ROBBINS, D. M., Hartman, C. R., Shader, R. I., Grunebaum, H. U., Gallant, D. H., & Weiss, J. L. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90017-5 · Cited by 132
The need for multiple time points in aging studies
Coleman, P. A., Finch, C. E., & Joseph, J. A. (1990) · Neurobiology of Aging · doi:10.1016/0197-4580(90)90055-5 · Cited by 66

Show all 16 references

Research works printed but not linked: 16

Altstiel L, Sperber K. Cytokines in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 1991;15:481-495.
Eikelenboom P, Stam FC. Immunoglobulins and complement factors in senile plaques: an immunohistochemical study. Acta Neuropathol (Berl) 1982;57:239-252.
Anonymous. The Canadian Study of Health and Aging: Risk factors for Alzheimer's disease in Canada. Neurology 1994;44:2073-2080.
Lucca U, Tettamanti M, Forloni G, Spagnoli A. Nonsteroidal antiinflammatory drug use in Alzheimer's disease. Biol Psychiatry 1994;36:854-856.
Andersen K, Launer LJ, Ott A, Hoes AW, Breteler MMB, Hofman A. Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? Neurology 1995;45:1441-1445.
Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile changes in the cerebral gray matter of elderly subjects. Br J Psychiatry 1968;114:797-811.
Benton AL. Differential behavioral effects in frontal lobe disease. Neuropsychologia 1968;6:53-60.
Rouleau I, Salmon DP, Butters N, Kennedy C, McGuire K. Quantitative and qualitative analyses of clock drawings in Alzheimer's and Huntington's disease. Brain Cogn 1992;18:70-87.
Morris JC, Mohs R, Rogers H, Fillenbaum G, Heyman A. Consortium to establish a Registry for Alzheimer's Disease (CERAD): clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacol Bull 1988;24:641-652.
Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
Pfeffer RI, Kurosaki TT, Harrah CH, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol 1982;37:323-329.
Nelson HE, O'Connell A. Dementia: the estimation of premorbid intelligence using the New Adult Reading Test. Cortex 1978;14:234-244.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
Checkoway H Pearce NE Crawford-Brown DJ. Research methods in occupational epidemiology monographs in epidemiology and biostatistics vol 13. New York: Oxford University Press 1989:153-155.
Aspirin Myocardial Infarction Study Group. A randomized controlled trial of aspirin in persons recovered from myocardial infarction. JAMA 1980;243:661-669.
Paulas HE. Nonsteroidal anti-inflammatory drugs. In: Kelley WN Harris ED Ruddy S Sledge CB eds. A textbook of rheumatology. Philadelphia: WB Saunders 1989.

Sorted by citations

Items 701–800 of 1,000

What Is the Rationale for New Treatment Strategies in Alzheimer's Disease?
Rogawski, M. A. (2004) · CNS Spectrums · doi:10.1017/s1092852900024743 · Cited by 19
Update on Alzheimer's disease
Burke, J. R., & Morgenlander, J. C. (1999) · Postgraduate Medicine · doi:10.3810/pgm.1999.10.15.746 · Cited by 19
Epidemiology of mental disorders in old age
Jorm, A. F. (1998) · Current Opinion in Psychiatry · doi:10.1097/00001504-199807000-00008 · Cited by 18
Celecoxib effect on rivastigmine anti-Alzheimer activity against aluminum chloride-induced neurobehavioral deficits as a rat model of Alzheimer's disease; novel perspectives for an old drug
Abdel‐Aal, R. A., Hussein, O. A., Elsaady, R. G., & Abdelzaher, L. A. (2021) · Journal of Medical and Life Science · doi:10.21608/jmals.2021.210630 · Cited by 17
Involvement of inflammasomes in the pathogenesis of Alzheimer's disease
Beder, N., Belkhelfa, M., & Leklou, H. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241283677 · Cited by 20
Activated Microglia in Alzheimer’s Disease and Stroke
Pocock, J. M., Liddle, A. C., Hooper, C., Taylor, D. L., Davenport, C. M., & Morgan, S. (2002) · Springer eBooks · doi:10.1007/978-3-662-05073-6_7 · Cited by 17
Interaction between Drug Loaded Polyaspartamide-Polylactide-Polysorbate Based Micelles and Cell Membrane Models: A Calorimetric Study
Sarpietro, M. G., Pitarresi, G. L., Ottimo, S., Giuffrida, M. C., Ognibene, M. C., Fiorica, C., Giammona, G., & Castelli, F. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100445k · Cited by 18
Determining the Molecular Pathways Underlying the Protective Effect of Non-Steroidal Anti-Inflammatory Drugs for Alzheimer's Disease: A Bioinformatics Approach
Nevado‐Holgado, A. J., & Lovestone, S. (2016) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2016.10.003 · Cited by 17
Neuroinflammation and Oxidative Injury in Developmental Neurotoxicity
Milatović, D., Zaja‐Milatovic, S., BREYER, R. M., Aschner, M., & Montine, T. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804239-7.00055-x · Cited by 22
Selective modulation of amyloid‐β peptide degradation by flurbiprofen, fenofibrate, and related compounds regulates Aβ levels
Abdul‐Hay, S. O., Edirisinghe, P. D., & Thatcher, G. R. J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06355.x · Cited by 17
15-O-Acetyl-3-O-benzoylcharaciol and helioscopinolide A, two diterpenes isolated from Euphorbia helioscopia suppress microglia activation
Wang, H., Liu, Y., Zhang, J., Xu, J., Cui, C., Guo, Y., & Jin, D. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.12.010 · Cited by 18
Histocompatibility antigens, aspirin use and cognitive performance in non-demented elderly subjects
Shepherd, C. E., Piguet, O., Broe, G. A., Creasey, H. M., Waite, L. M., Brooks, W. S., & Kril, J. J. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.11.007 · Cited by 18
Non‐steroidal anti‐inflammatory drugs mediate increased in vitro glial expression of apolipoprotein E protein
Aleong, R., Aumont, N., Dea, D., & Poirier, J. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02869.x · Cited by 18
Vascular nitric oxide, sex hormone replacement, and fish oil may help to prevent Alzheimer's disease by suppressing synthesis of acute-phase cytokines
McCarty, M. F. (1999) · Medical Hypotheses · doi:10.1054/mehy.1998.0783 · Cited by 18
The prediction and prevention of Alzheimer's disease--towards a research agenda.
van Reekum, R., Simard, M., & Cohen, T. (1999) · PubMed Central · Cited by 18
Association between interleukin-6 −174G/C polymorphism and the risk of Alzheimer's disease: a meta-analysis
Ye, H., Guo, X., Huang, Q., Kong, Y., & Lu, X. (2013) · International Journal of Neuroscience · doi:10.3109/00207454.2013.784286 · Cited by 17
Brain-Derived Neurotrophic Factor Gene Variants and Alzheimer Disease: An Association Study in an Alzheimer Disease Italian Population
Boiocchi, C., Maggioli, E., Zorzetto, M., Sinforiani, E., Cereda, C., Ricevuti, G., & Cuccia, M. (2012) · Rejuvenation Research · doi:10.1089/rej.2012.1381 · Cited by 17
Neuroprotection in alzheimer’s disease — new strategies for treatment
Nordberg, A. K. (2000) · Neurotoxicity Research · doi:10.1007/bf03033791 · Cited by 17
Isoindol-1,3-dione and isoindol-1-one derivatives with high binding affinity to β-amyloid fibrils
Lee, H. J., Lim, S. J., Oh, S. J., Moon, D. H., Kim, D. J., Tae, J., & Yoo, K. H. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.01.066 · Cited by 17
Potential Use of Nanomedicine for the Anti-inflammatory Treatment of Neurodegenerative Diseases
Otero, M. D. C., Espinosa‐Oliva, A. M., Herrera, A. J., García-Domínguez, I., Arévalo, M. F., Martín‐Banderas, L., & de Pablos, R. M. (2018) · Current Pharmaceutical Design · doi:10.2174/1381612824666180403113015 · Cited by 17
Neurodegeneration and Aging of the Central Nervous System
Blaylock, R. L. (1998) · Integrative medicine · doi:10.1016/s1096-2190(98)00032-8 · Cited by 17
Clinical pharmacology of anti‐Alzheimer drugs
Pettenati, C., Annicchiarico, R., & Caltagirone, C. (2003) · Fundamental and Clinical Pharmacology · doi:10.1046/j.1472-8206.2003.00204.x · Cited by 17
Experimental Approaches to Cognitive Disturbance in Alzheimer's Disease
Samuels, S. C., & Davis, K. L. (1998) · Harvard Review of Psychiatry · doi:10.3109/10673229809010950 · Cited by 17
Non-Steroidal Antiinflammatory Drugs
Childre, F., Winzeler, S., & Rosenstein, B. D. (1998) · AAOHN Journal · doi:10.1177/216507999804600505 · Cited by 17
Cyclooxygenase-2 activity contributes to neuronal expression of cyclin D1 after anoxia/ischemia in vitro and in vivo
Chen, R. W., Zhang, Y., Rose, M. E., & Graham, S. H. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.08.020 · Cited by 17
Utilizing combination therapy in the treatment of Alzheimer’s disease
Farlow, M. R. (2004) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.4.5.799 · Cited by 17
Mitochondrial dysfunction in diabetes mellitus
Anderson, C. M. (1999) · Drug Development Research · doi:10.1002/(sici)1098-2299(199901)46:1 · Cited by 18
Current Concepts in the Prevention of Alzheimer's Disease
Sano, M. (2003) · CNS Spectrums · doi:10.1017/s1092852900019283 · Cited by 17
Immunotherapy for Alzheimer's Disease
McGeer, P. L., & McGeer, E. G. (2004) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2004.27.pe29 · Cited by 16
Hydrocortisone Mitigates Alzheimer’s-Related Cognitive Decline through Modulating Oxidative Stress and Neuroinflammation
Li, J., Chen, L., Liu, S., Sun, Y., Zhen, L., Zhu, Z., Wang, G., & Li, X. (2023) · Cells · doi:10.3390/cells12192348 · Cited by 18
Microglia PTK2B/Pyk2 in the Pathogenesis of Alzheimer’s Disease
Guo, Y., Sun, C.-K., Tang, L., & Tan, M. (2023) · Current Alzheimer Research · doi:10.2174/0115672050299004240129051655 · Cited by 17
Ibuprofen Rescues Abnormalities in Periodontal Tissues in Conditional Presenilin 1 and Presenilin 2 Double Knockout Mice
Su, J., Gu, J., Dong, Z., & Mei, B. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140918457 · Cited by 16
Iso-α-Acids, Bitter Components in Beer, Suppress Inflammatory Responses and Attenuate Neural Hyperactivation in the Hippocampus
Ano, Y., Yoshikawa, M., Takaichi, Y., Michikawa, M., Uchida, K., Nakayama, H., & Takashima, A. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00081 · Cited by 17
Alzheimer's Disease: Fatty Acids We Eat may be Linked to a Specific Protection via Low-dose Aspirin.
Pomponi, M. F. L., Gambassi, G., Pomponi, M., & Masullo, C. (2010) · Europe PMC (PubMed Central) · Cited by 15
Indomethacin Increases Neurogenesis across Age Groups and Improves Delayed Probe Trial Difference Scores in Middle-Aged Rats
McGuiness, J., Scheinert, R. B., Asokan, A., Stadler, V.-C., Lee, C. S., Rani, A., Kumar, A., Foster, T. C., & Ormerod, B. K. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00280 · Cited by 15
Les anti-inflammatoires non stéroïdiens inhibiteurs sélectifs de la cyclooxygénase 2.Intérêt et perspectives
Blain, H., Jouzeau, J., Netter, P., & Jeandel, C. (2000) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(00)00254-x · Cited by 16
S-2474, a novel nonsteroidal anti-inflammatory drug, rescues cortical neurons from human group IIA secretory phospholipase A-induced apoptosis
Yagami, T., UEDA, K., Hata, S., KURODA, T., Itoh, N., Sakaguchi, G., Okamura, N., Sakaeda, T., & Fujimoto, M. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.02.011 · Cited by 16
Effect of Non-Steroidal Anti-Inflammatory Drugs on Amyloid-β Formation and Macrophage Activation after Platelet Phagocytosis
Jans, D. M., Martinet, W., Fillet, M., Kockx, M. M., Merville, M., Bult, H., Herman, A. G., & Meyer, G. R. Y. D. (2004) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200403000-00019 · Cited by 16
Chapter 3 Secretase Inhibitors and Modulators for the Treatment of Alzheimer's Disease
Olson, R. E., & Marcin, L. R. (2007) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(07)42003-6 · Cited by 16
The status of ongoing trials for mild cognitive impairment
Sramek, J. J., Veroff, A. E., & Cutler, N. R. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.4.741 · Cited by 16
New Biochemical Markers in Alzheimer Disease
Diaz-Arrastia, R. R., & Baskin, F. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.354 · Cited by 16
Pharmacogenomics for neurodegenerative disorders - a focused review
Ahmad, S. R., Zeyaullah, M., Khan, M. S. A. A., AlShahrani, A. M., Altijani, A. A. G., Ali, H., Dawria, A., Mohieldin, A., Alam, M. S., & Mohamed, A. O. A. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1478964 · Cited by 17
Anti-Inflammatory Agents: An Approach to Prevent Cognitive Decline in Alzheimer’s Disease
Brod, S. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215125 · Cited by 16
Pathology of Neurodegenerative Diseases
Kim, Y. S., Kim, Y.-K., Hwang, O., & Dong, J. (2012) · InTech eBooks · doi:10.5772/38028 · Cited by 16
Estrés oxidativo, péptido β-amiloide y enfermedad de Alzheimer
Manzano‐León, N., & Mas‐Oliva, J. (2006) · Gaceta Médica de México · Cited by 16
Memory-enhancing effect of aspirin is mediated through opioid system modulation in an AlCl3-induced neurotoxicity mouse model
Rizwan, S., IDREES, A., Ashraf, M., & Ahmed, T. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3147 · Cited by 15
Deciphering an interplay of proteins associated with amyloid β 1-42 peptide and molecular mechanisms of Alzheimer’s disease
Hernández-Zimbrón, L. F., & Rivas-Arancibia, S. (2014) · Reviews in the Neurosciences · doi:10.1515/revneuro-2014-0025 · Cited by 17
EFFECT OF CURCUMIN LIPOSOMAL FORM ON ANGIOTENSIN CONVERTING ACTIVITY, CYTOKINES AND COGNITIVE CHARACTERISTICS OF THE RATS WITH ALZHEIMER’S DISEASE MODEL
V., V. (2015) · Biotechnologia Acta · doi:10.15407/biotech8.06.048 · Cited by 15
Potential Roles of Myeloid Differentiation Factor 2 on Neuroinflammation and Its Possible Interventions
Oo, T. T., Pratchayasakul, W., Chattipakorn, N., & Chattipakorn, S. C. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02066-2 · Cited by 15
Role of fibrillar Aβ25–35in the inflammation induced rat model with respect to oxidative vulnerability
Masilamoni, J. G., Jesudason, E. P., Jesudoss, K. S., Murali, J., Paul, S. F. D., & Rajadas, J. (2005) · Free Radical Research · doi:10.1080/10715760500117373 · Cited by 15
Cyclooxygenase-2 Immunoreactivity and Protein Level in the Gerbil Hippocampus During Normal Aging
Lee, C. H., Yoo, K., Choi, J. H., Park, O. K., Hwang, I. K., Kang, I., & Won, M. (2009) · Neurochemical Research · doi:10.1007/s11064-009-0034-5 · Cited by 15
Neuroprotective Agents
Richardson, J. S. (1999) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/s1047-9651(18)30205-5 · Cited by 15
Clinical Potential of Cyclo-Oxygenase-2 Inhibitors
Oviedo, J. A., & Wolfe, M. M. (2001) · BioDrugs · doi:10.2165/00063030-200115090-00001 · Cited by 15
Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy-verified sample
Luis, C. A., Barker, W., Gajaraj, K., Harwood, D. G., Petersen, R., Kashuba, A., Waters, C., Jimison, P., Pearl, G. S., Petito, C. K., et al. (1999) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199907)14:7 · Cited by 140
Promising agents for treating Alzheimer’s disease
Simonson, W. (1998) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/55.suppl_2.s11 · Cited by 15
Fish consumption, cancer, and Alzheimer disease
Grant, W. B. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.2.599 · Cited by 15
Naproxen as a potential candidate for promoting rivastigmine anti-Alzheimer activity against aluminum chloride-prompted Alzheimer's-like disease in rats; neurogenesis and apoptosis modulation as a possible underlying mechanism
Abdel‐Aal, R. A., Hussein, O. A., Elsaady, R. G., & Abdelzaher, L. A. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174695 · Cited by 17
Amelioration of cognitive ability in senescence-accelerated mouse prone 8 (SAMP8) by intra-bone marrow-bone marrow transplantation
Li, M., Inaba, M., Guo, K., Abraham, N. G., & Ikehara, S. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.09.001 · Cited by 14
Alismol, a Sesquiterpenoid Isolated from Vladimiria souliei, Suppresses Proinflammatory Mediators in Lipopolysaccharide-Stimulated Microglia
Shi, D., Song, X., Guo, Y., Xu, J., Liu, Y., Zhang, J., Cui, C., & Jin, D. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0890-4 · Cited by 14
Pharmacology, Pharmaceutics and Clinical Use of Aspirin: A Narrative Review
Alegbeleye, B. J., Akpoveso, O.-O. P., Mohammed, R. K., & Asiamah-Asare, B. K. Y. (2020) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v10i5-s.4351 · Cited by 15
Can beta stiffness index be proposed as risk factor for dementia
Jurašić, M., Popović, I. M., Morović, S., Trkanjec, Z., Šerić, V., & Demarin, V. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.02.339 · Cited by 14
Chronic inflammation in Alzheimer’s disease offers therapeutic opportunities
McGeer, E. G., & McGeer, P. L. (2001) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.1.1.53 · Cited by 14
Approach towards an integrative drug treatment of Alzheimer’s disease
Windisch, M. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6781-6_32 · Cited by 14
A 90-year-old monozygotic female twin pair discordant for Alzheimer’s disease
Järvenpää, T., Räihä, I. J., Kaprio, J. A., Koskenvuo, M. J., Laine, M., Kurki, T. J. I., Viljanen, T., & Rinne, J. O. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00008-3 · Cited by 14
The Role of Aβ-Peptide on Spatial Memory, EEG, Auditory Evoked Potentials And Nicotinic Cholinergic Receptors in A/P Transgenic Mice
Wang, J. (2003) · Cited by 14
Gliosis in relation to Alzheimer's hallmark lesions in aging and Alzheimer's disease
Overmyer, M. (2002) · Cited by 14
Neuroinflammation and Oxidative Stress in Alzheimer’s Disease; Can Nutraceuticals and Functional Foods Come to the Rescue?
Onaolapo, O. J., Olofinnade, A. T., Ojo, F. O., & Onaolapo, A. Y. (2021) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/1871523021666220815151559 · Cited by 12
Aspirin Therapy, Cognitive Impairment, and Dementia—A Review
Thong, E. H., Lee, E. C. Y., Yun, C.-Y., Li, T. Y., & Sia, C. (2023) · Future Pharmacology · doi:10.3390/futurepharmacol3010011 · Cited by 13
Osteoarthritis, osteoarthritis treatment and risk of incident dementia: a prospective cohort study based on UK Biobank
Guo, R., Ou, Y., Ma, L., Tang, L., Yang, L., Feng, J., Cheng, W., Tan, L., & Yu, J. (2024) · Age and Ageing · doi:10.1093/ageing/afae167 · Cited by 13
Sex‐ and region‐dependent neuroinflammation in Alzheimer's disease
Acosta‐Martínez, M., Carter, V., Nessim, A., Panchal, R., John, D., Dhawan, J., Beach, T. G., Serrano, G. E., Sundermann, E. E., & Biegon, A. R. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14603 · Cited by 15
Neuroinflammation and oxidative injury in developmental neurotoxicity
Milatović, D., Zaja‐Milatovic, S., BREYER, R. M., Aschner, M., & Montine, T. J. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-382032-7.10064-5 · Cited by 13
Neuroinflammation and Alzheimer’s disease: lessons learned from 5-lipoxygenase
Joshi, Y. B., & Praticò, D. (2014) · Translational Neuroscience · doi:10.2478/s13380-014-0225-7 · Cited by 12
Intermittent Fasting and Brain Health: Efficacy and Potential Mechanisms of Action
Francis, N. (2020) · OBM Geriatrics · doi:10.21926/obm.geriatr.2002121 · Cited by 14
Medications and Diet
Kawas, C. H. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200607001-00014 · Cited by 15
Self-citation
Patents targeting γ-secretase inhibition and modulation for the treatment of Alzheimer's disease: 2004 – 2008
Garofalo, A. W. (2008) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.18.7.693 · Cited by 13
Causes of Alzheimer’s disease: paracetamol (acetaminophen) today? Amphetamines tomorrow?
Jones, G. R. N. (2001) · Medical Hypotheses · doi:10.1054/mehy.2000.1235 · Cited by 13
Cyclooxygenase-2 plays a critical role in retinal ganglion cell death after transient ischemia: Real-time monitoring of RGC survival using Thy-1-EGFP transgenic mice
Sakai, Y., Tanaka, T., Seki, M., Okuyama, S., Fukuchi, T., Yamagata, K., Takei, N., Nawa, H., & Abe, H. (2009) · Neuroscience Research · doi:10.1016/j.neures.2009.08.008 · Cited by 13
Regular Aspirin Use Does Not Reduce Risk of Cognitive Decline
Kelley, B. J., McClure, L. A., Unverzagt, F. W., D, B. M. K. M., Kleindorfer, D., Howard, G., & Wadley, V. G. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13271 · Cited by 13
Preventing Dementia
Black, S. E., Patterson, C., & Feightner, J. (2001) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100001219 · Cited by 13
Association of Nonsteroidal Anti-Inflammatory Drugs and Aspirinwith Cognitive Performance inMiddle-Aged Adults
Peacock, J. M., Folsom, A. R., Knopman, D. S., Mosley, T. H., Goff, D. C., & Szklo, M. (1999) · Neuroepidemiology · doi:10.1159/000026205 · Cited by 13
Computer‐aided design of selective COX‐2 inhibitors: comparative molecular field analysis and docking studies of some 3,4‐diaryloxazolone derivatives
Desiraju, G. R., Sarma, J. A. R. P., Raveendra, D., Gopalakrishnan, B., Thilagavathi, R., Sobhia, M. E., & Subramanya, H. S. (2001) · Journal of Physical Organic Chemistry · doi:10.1002/poc.393 · Cited by 13
Mild Cognitive Impairment: Emerging Therapeutics
Sramek, J. J., Veroff, A. E., & Cutler, N. R. (2000) · Annals of Pharmacotherapy · doi:10.1345/aph.19394 · Cited by 13
Tratamiento del deterioro cognitivo leve: utilidad de la citicolina
Abad‐Santos, F., Novalbos, J., Gallego‐Sandín, S., & García, A. G. (2002) · Revista de Neurología · doi:10.33588/rn.3507.2002390 · Cited by 13
Prevention of Cognitive Impairment in the Midlife Women
Kim, S. A., & Jung, H. (2015) · Journal of Menopausal Medicine · doi:10.6118/jmm.2015.21.1.19 · Cited by 12
Meta‐analysis of the association between the interleukin‐1A −889C/T polymorphism and Alzheimer's disease
Ye, H., Zhao, H., Kong, Y., & Lu, X. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23062 · Cited by 12
Long-Term Pantethine Treatment Counteracts Pathologic Gene Dysregulation and Decreases Alzheimer's Disease Pathogenesis in a Transgenic Mouse Model
Baranger, K., van Gijsel‐Bonnello, M., Stephan, D., Carpentier, W., Rivera, S., Khrestchatisky, M., Gharib, B., Reggi, M. L. D., & Benech, P. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00754-z · Cited by 13
Dexibuprofen ameliorates peripheral and central risk factors associated with Alzheimer’s disease in metabolically stressed APPswe/PS1dE9 mice
Ettcheto, M., Sánchez‐López, E., Cano, A. C., Carrasco, M., Herrera, K., Manzine, P. R., Espinosa-Jiménez, T., Busquets, O., Verdaguer, E., Olloquequi, J., et al. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00646-w · Cited by 12
Alzheimer disease prevention: Focus on cardiovascular risk, not amyloid?
Geldmacher, D. (2010) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.77gr.2010 · Cited by 12
Expression of proteins linked to Alzheimer’s disease in C6 rat glioma cells under the action of lipopolysaccharide (LPS), nimesulide, resveratrol and citalopram
Martínez-Díaz, J. A., Hernández‐Aguilar, M. E., Rojas-Durán, F., Herrera‐Covarrubias, D., García, L. I., Mestizo-Gutiérrez, S. L., & Aranda-Abreu, G. E. (2020) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2020-0091 · Cited by 12
The use of complementary medicine for healthy aging.
Bland, J. S. (1998) · PubMed · Cited by 12
The discovery, development and novel actions of nimesulide
Rainsford, K. D. (2005) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7410-1_1 · Cited by 12
Nonsteroidal Anti-Inflammatory Drugs and Alzheimer??s Disease
Lucca, U. (1999) · CNS Drugs · doi:10.2165/00023210-199911030-00005 · Cited by 11
Part I. Epidemiology and public health impact of Alzheimer's disease
Bennett, D. A. (2000) · Disease-a-Month · doi:10.1016/s0011-5029(00)90028-2 · Cited by 12
Alzheimer Disease: Current Therapy and Future Therapeutic Strategies
Hirai, S. (2000) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200000001-00003 · Cited by 12
Induction of Cyclooxygenase‐2 and Peroxisome Proliferator‐Activated Receptor‐γ during Nitric Oxide‐Induced Apoptotic PC12 Cell Death
LIM, S., Jang, J.-H., & Surh, Y. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1299.119 · Cited by 12
The Validation of a Mailed Health Survey for Screening of Dementia of the Alzheimer's Type
Ball, L. J., Ogden, A. D., Mandi, D., & Birge, S. J. (2001) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2001.49159.x · Cited by 12
Evidence‐Based Medicine Holds the Key to the Future for Geriatric Medicine
Burns, R. A., Pahor, M., & Shorr, R. I. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb03782.x · Cited by 12
Discovery of a highly selective BChE inhibitor with concomitant anti-neuroinflammatory activity for treating Alzheimer's disease
Zhao, Y., Wu, K., Luo, W., Zhao, Y., Zeng, J., Wu, J., Yang, C., Yang, M., Liu, J., Lei, Z., et al. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118071 · Cited by 12
From the Bush to the Brain: Preclinical Stages of Ethnobotanical Anti-Inflammatory and Neuroprotective Drug Discovery—An Australian Example
Kumar, P., Mathew, S., Gamage, R. V., Bodkin, F., Doyle, K., Rosetti, I., Wagnon, I. M., Zhou, X., Raju, R., Gyengési, E., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311086 · Cited by 12
Association of regular use of ibuprofen and paracetamol, genetic susceptibility, and new-onset dementia in the older population
Zhang, Y., Zhou, C., Yang, S., Zhang, Y., Ye, Z., He, P., Liu, M., Wu, Q., & Qin, X. (2023) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2023.08.006 · Cited by 11

Authors: Stewart, W. F., Kawas, C., Corrada, M., & Metter, E. J.
Affiliations: Johns Hopkins University (US)
ORCID: Stewart, Walter F.
Kawas, Claudia
Metter, E. Jeffrey
Venue: Neurology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1997-03
Volume: 48
Issue: 3
Pages: 626-632
ISSN: 0028-3878 (ISSN-L)
1526-632X
DOI: 10.1212/wnl.48.3.626
OpenAlex: W2163110760
Cited by: 1,132
References: 16
Citations by year: 2026: 5 · 2025: 9 · 2024: 13 · 2023: 22 · 2022: 19 · 2021: 22 · 2020: 23 · 2019: 22 · 2018: 21 · 2017: 24 · 2016: 28 · 2015: 29 · 2014: 32 · 2013: 24 · 2012: 31
FWCI: 42.05
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Neurology (publishedVersion)
PubMed (publishedVersion)
eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders: American Academy of Neurology
National Institutes of Health
National Institute on Aging (R01AG008325, R01-AG08325)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
Keywords: Alzheimer's disease, nonsteroidal anti-inflammatory drugs, aspirin, paracetamol, medication use, neuroprotection, neuroinflammation
MeSH terms: Acetaminophen, Aged, Aged, 80 and over, Alzheimer Disease, Anti-Inflammatory Agents, Non-Steroidal, Aspirin, Drug Administration Schedule, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Prospective Studies, Confidence Intervals, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Risk of Alzheimer's disease and duration of NSAID use

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks